Novo Nordisk faces potential layoffs after a period of rapid expansion fueled by the success of Wegovy. The company’s workforce nearly doubled in five years, but slowing sales and increased competition are now putting pressure on costs. A hiring freeze is in place, and analysts anticipate cuts, particularly in sales, as Novo seeks to regain market share and improve profitability.